DANIEL GONZALEZ: Open Payments
NPI 1851850150 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 42 payments from 10 companies in 2025. Trend: 2023 $486 · 2024 $371 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| Novo Nordisk Inc | 10 | $158 |
| ABBVIE INC. | 14 | $137 |
| Amgen Inc. | 3 | $43 |
| Dexcom, Inc. | 2 | $33 |
| Abbott Laboratories | 1 | $25 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
Products named: FARXIGA, Ozempic, VRAYLAR, Rybelsus, QULIPTA, AIRSUPRA, Dexcom G6 Transmitter, OTEZLA.
Industry payments across SC — which companies pay providers there.
